501 related articles for article (PubMed ID: 26493248)
1. Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.
Kereiakes DJ; Yeh RW; Massaro JM; Driscoll-Shempp P; Cutlip DE; Steg PG; Gershlick AH; Darius H; Meredith IT; Ormiston J; Tanguay JF; Windecker S; Garratt KN; Kandzari DE; Lee DP; Simon DI; Iancu AC; Trebacz J; Mauri L;
JACC Cardiovasc Interv; 2015 Oct; 8(12):1552-62. PubMed ID: 26493248
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial.
Kereiakes DJ; Yeh RW; Massaro JM; Driscoll-Shempp P; Cutlip DE; Steg PG; Gershlick AH; Darius H; Meredith IT; Ormiston J; Tanguay JF; Windecker S; Garratt KN; Kandzari DE; Lee DP; Simon DI; Iancu AC; Trebacz J; Mauri L;
JAMA; 2015 Mar; 313(11):1113-21. PubMed ID: 25781440
[TBL] [Abstract][Full Text] [Related]
3. Duration of dual antiplatelet therapy following drug-eluting stent implantation: A systemic review and meta-analysis of randomized controlled trials with longer follow up.
Sharma A; Agrawal S; Garg A; Vallakati A; Lavie CJ; Helft G
Catheter Cardiovasc Interv; 2017 Jul; 90(1):31-37. PubMed ID: 28557264
[TBL] [Abstract][Full Text] [Related]
4. Comparison of drug-eluting stents with bare metal stents in unselected patients with acute myocardial infarction.
Kupferwasser LI; Amorn AM; Kapoor N; Lee MS; Kar S; Cercek B; Dohad S; Mirocha J; Forrester JS; Shah PK; Makkar RR
Catheter Cardiovasc Interv; 2007 Jul; 70(1):1-8. PubMed ID: 17580366
[TBL] [Abstract][Full Text] [Related]
5. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.
Slottow TL; Steinberg DH; Roy P; Javaid A; Buch AN; Okabe T; Xue Z; Smith K; Torguson R; Pichard AD; Satler LF; Suddath WO; Kent KM; Waksman R
Cardiovasc Revasc Med; 2008; 9(1):24-8. PubMed ID: 18206634
[TBL] [Abstract][Full Text] [Related]
6. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.
Eisenstein EL; Anstrom KJ; Kong DF; Shaw LK; Tuttle RH; Mark DB; Kramer JM; Harrington RA; Matchar DB; Kandzari DE; Peterson ED; Schulman KA; Califf RM
JAMA; 2007 Jan; 297(2):159-68. PubMed ID: 17148711
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and prognosis of patients with angiographic stent thrombosis: comparison between drug-eluting and bare-metal stents.
Le Feuvre C; Helft G; Cohen S; Batisse JP; Barthélémy O; Collet JP; Beygui F; Choussat R; Montalescot G; Metzger JP
Arch Cardiovasc Dis; 2008 Apr; 101(4):220-5. PubMed ID: 18654096
[TBL] [Abstract][Full Text] [Related]
8. Is late stent thrombosis in drug-eluting stents a real clinical issue? A single-center experience and review of the literature.
Carlsson J; von Wagenheim B; Linder R; Anwari TM; Qvist J; Petersson I; Magounakis T; Lagerqvist B
Clin Res Cardiol; 2007 Feb; 96(2):86-93. PubMed ID: 17180577
[TBL] [Abstract][Full Text] [Related]
9. An Aspirin-Free Strategy for Immediate Treatment Following Complex Percutaneous Coronary Intervention.
Yamamoto K; Natsuaki M; Watanabe H; Morimoto T; Obayashi Y; Nishikawa R; Ando K; Suwa S; Isawa T; Takenaka H; Ishikawa T; Tamura T; Kawahatsu K; Hayashi F; Akao M; Serikawa T; Mori H; Kawamura T; Hagikura A; Shibata N; Ono K; Kimura T;
JACC Cardiovasc Interv; 2024 May; 17(9):1119-1130. PubMed ID: 38749592
[TBL] [Abstract][Full Text] [Related]
10. [Drug-eluting stent-associated thrombosis: clinical relevance of impaired vessel-wall healing].
Koziński M; Sukiennik A; Sinkiewicz W; Kochman W; Kubica J
Postepy Hig Med Dosw (Online); 2008 May; 62():185-205. PubMed ID: 18464681
[TBL] [Abstract][Full Text] [Related]
11. Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients).
Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Hong MK; Kim HS; Ko JK; Park JH; Lee JH; Choi SW; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Park SJ
J Am Coll Cardiol; 2008 Mar; 51(12):1181-7. PubMed ID: 18355656
[TBL] [Abstract][Full Text] [Related]
12. Frequency of coronary arterial late angiographic stent thrombosis (LAST) in the first six months: outcomes with drug-eluting stents versus bare metal stents.
Park DW; Park SW; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Park SJ
Am J Cardiol; 2007 Mar; 99(6):774-8. PubMed ID: 17350363
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of drug-eluting stents for patients at high risk of bleedings: A network meta-analysis.
Giacobbe F; Valente E; Morena A; Nebiolo M; Giannino G; De Filippo O; Bruno F; Isaevska E; Richiardi L; Iannaccone M; Zoccai GB; Burzotta F; D'Ascenzo F; Ferrari GM
Catheter Cardiovasc Interv; 2024 May; 103(6):843-855. PubMed ID: 38639169
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial comparing eptifibatide vs. placebo in patients with diffuse coronary artery disease undergoing drug-eluting stent implantation: design of the INtegrilin plus STenting to Avoid myocardial Necrosis Trial.
Biondi-Zoccai GG; Valgimigli M; Sheiban I; Margheri M; Marzocchi A; Prati F; Vischi M; Lettieri C; Violini R; Sardella G; Stabile A; Clementi F; Romeo F; Colombo A; Sangiorgi G
J Cardiovasc Med (Hagerstown); 2008 Sep; 9(9):957-62. PubMed ID: 18695440
[TBL] [Abstract][Full Text] [Related]
15. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.
Pfisterer M; Brunner-La Rocca HP; Buser PT; Rickenbacher P; Hunziker P; Mueller C; Jeger R; Bader F; Osswald S; Kaiser C;
J Am Coll Cardiol; 2006 Dec; 48(12):2584-91. PubMed ID: 17174201
[TBL] [Abstract][Full Text] [Related]
16. Selection of Stent Type in Patients With Atrial Fibrillation Presenting With Acute Myocardial Infarction: An Analysis From the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry-Get With the Guidelines.
Vora AN; Wang TY; Li S; Chiswell K; Hess C; Lopes RD; Rao SV; Peterson ED
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862960
[TBL] [Abstract][Full Text] [Related]
17. Predictors and Long-Term Clinical Impact of Acute Stent Malapposition: An Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents (ADAPT-DES) Intravascular Ultrasound Substudy.
Wang B; Mintz GS; Witzenbichler B; Souza CF; Metzger DC; Rinaldi MJ; Duffy PL; Weisz G; Stuckey TD; Brodie BR; Matsumura M; Yamamoto MH; Parvataneni R; Kirtane AJ; Stone GW; Maehara A
J Am Heart Assoc; 2016 Dec; 5(12):. PubMed ID: 28007741
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of dual antiplatelet therapy after percutaneous coronary drug-eluting stenting: A network meta-analysis.
Luo L; Wang S; Tang K; Yang X; Wu J; Wang D; Xu L; Feng T; Li D; Ran J; Li D; Zhang L; Zhao D
Medicine (Baltimore); 2022 Oct; 101(42):e31158. PubMed ID: 36281144
[TBL] [Abstract][Full Text] [Related]
19. Comparison of drug-eluting stents versus bare-metal stents for treating ST-segment elevation myocardial infarction.
Shishehbor MH; Amini R; Oliveria LP; Singh IM; Kelly P; Bhatt DL; Kapadia SR; Ellis SG; Whitlow PL; Brener SJ
JACC Cardiovasc Interv; 2008 Jun; 1(3):227-32. PubMed ID: 19463304
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous Coronary Interventions Using a Ridaforolimus-Eluting Stent in Patients at High Bleeding Risk.
Kornowski R; Konigstein M; Jonas M; Assali A; Vaknin-Assa H; Segev A; Danenberg H; Halabi M; Roguin A; Kerner A; Lev E; Karamasis GV; Johnson TW; Anderson R; Blaxill J; Jadhav S; Hoole S; Witberg G; Issever MO; Ben-Yehuda O; Baumbach A
J Am Heart Assoc; 2024 Jan; 13(2):e029051. PubMed ID: 38214256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
